O. Fedorov
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Molecular Biology top 1%
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
Papers in
-
- Protein Degradation and Inhibitors 28
- Histone Deacetylase Inhibitors Research 9
- Ubiquitin and proteasome pathways 9
- Protein Kinase Regulation and GTPase Signaling 7
- Epigenetics and DNA Methylation 5
- Hematology 18
- Multiple Myeloma Research and Treatments 18
- Co-authors
- Stefan Knapp (43 shared papers)Susanne Müller (15 shared papers)P. Filippakopoulos (20 shared papers)Brian D. Marsden (8 shared papers)S. Picaud (14 shared papers)Paul E. Brennan (15 shared papers)Alex N. Bullock (6 shared papers)Martin Philpott (10 shared papers)
- Journals
- Journal of Medicinal Chemistry (11 papers)Proceedings of the National Academy of Sciences (6 papers)Structure (4 papers)Angewandte Chemie International Edition (3 papers)Bioorganic & Medicinal Chemistry (3 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
O. Fedorov
56 papers receiving 5.3k citations
Peers
Comparison fields: 5 of 125
- Hematology 1.2k
- Molecular Biology 4.4k
- Oncology 832
- Computational Theory and Mathematics 462
- Virology 124
Countries citing papers authored by O. Fedorov
This map shows the geographic impact of O. Fedorov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Fedorov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Fedorov more than expected).
Fields of papers citing papers by O. Fedorov
This network shows the impact of papers produced by O. Fedorov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Fedorov. The network helps show where O. Fedorov may publish in the future.
Co-authors
The 25 scholars most cited alongside O. Fedorov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 471 | |
| 2 | 2013 | 360 | |
| 3 | 2007 | 279 | |
| 4 | 2014 | 261 | |
| 5 | 2010 | 228 | |
| 6 | 2015 | 195 | |
| 7 | 2013 | 193 | |
| 8 | 2011 | 172 | |
| 9 | 2007 | 169 | |
| 10 | 2011 | 163 | |
| 11 | 2008 | 156 | |
| 12 | 2015 | 134 | |
| 13 | 2011 | 128 | |
| 14 | 2005 | 127 | |
| 15 | 2011 | 119 | |
| 16 | 2013 | 117 | |
| 17 | 2015 | 111 | |
| 18 | 2011 | 107 | |
| 19 | 2013 | 103 | |
| 20 | 2013 | 101 |
About O. Fedorov
O. Fedorov is a scholar working on Molecular Biology, Hematology, Oncology, Pathology and Forensic Medicine and Organic Chemistry, having authored 56 papers that have together received 5.4k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (28 papers), Multiple Myeloma Research and Treatments (18 papers), Histone Deacetylase Inhibitors Research (9 papers), Ubiquitin and proteasome pathways (9 papers), Peptidase Inhibition and Analysis (8 papers), Protein Kinase Regulation and GTPase Signaling (7 papers), Cancer Mechanisms and Therapy (6 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Hematology (1.2k citations), Molecular Biology (4.4k citations), Oncology (832 citations), Computational Theory and Mathematics (462 citations) and Virology (124 citations). O. Fedorov has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Stefan Knapp, Susanne Müller, P. Filippakopoulos, Brian D. Marsden, S. Picaud, Paul E. Brennan, Alex N. Bullock, Martin Philpott, M. Sundström and F. Niesen. Their work appears in journals such as Journal of Medicinal Chemistry, Proceedings of the National Academy of Sciences, Structure, Angewandte Chemie International Edition and Bioorganic & Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.